Original Research | By Hamilos M, Muller O, Cuisset T et al.
Original Research | By Jasti V, Ivan E, Yalamanchili V et al.
Original Research | By Daniels DV, van't Veer M, Pijls NH et al.
Coronary fractional flow reserve in bifurcation stenoses: what have we learned?
Review Article | By Lee JM, Koo BK, Kumsars I et al.
Fractional flow reserve (FFR) is a useful tool for the evaluation of coronary bifurcation lesions. FFR can guide treatment strategy, simplify the procedure and reduce unnecessary complex interventions. However, the application of FFR to complex bifurcation lesions requires a comprehensive understanding of its roles and potential pitfalls. Furthermore, FFR should be interpreted in the context of complex bifurcation anatomy and physio...
Clinical Trial | By H Thiele , U Zeymer, IABPSHOCK II Trial investigators.
BACKGROUND - In current international guidelines the recommendation for intra-aortic balloon pump (IABP) use has been downgraded in cardiogenic shock complicating acute myocardial infarction on the basis of registry data. In the largest randomised trial (IABP-SHOCK II), IABP support did not reduce 30 day mortality compared with control. However, previous trials in cardiogenic shock showed a mortality benefit only at exte...
Clinical Trial | By Abdin A, Pöss J, Thiele H et al.
BACKGROUND - Limited data from observational retrospective studies suggest an association between glucose levels and prognosis of patients with cardiogenic shock (CS). The aim of this study was to investigate the prognostic role of glucose at admission in patients with acute myocardial infarction (AMI) complicated by CS included in the largest CS trial to date, the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHO...
Clinical Trial | By Abdin A, Pöss J, Thiele H et al.
BACKGROUND - Limited data from observational retrospective studies suggest an association between glucose levels and prognosis of patients with cardiogenic shock (CS). The aim of this study was to investigate the prognostic role of glucose at admission in patients with acute myocardial infarction (AMI) complicated by CS included in the largest CS trial to date, the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-S...